Second Sight Medical Products Inc. (EYES) is priced at $4.32 after the most recent trading session. At the very opening of the session, the stock price was $3.87 and reached a high price of $4.40, prior to closing the session it reached the value of $3.85. The stock touched a low price of $3.86.
Recently in News on June 25, 2021, Second Sight Medical Products Announces Closing of Public Offering. Second Sight Medical Products, Inc. (NASDAQ: EYES) (“Second Sight” or the “Company”), a leading developer of implantable visual prosthetics that are intended to create an artificial form of useful vision for blind individuals, today announced the closing of its previously announced underwritten public offering of 11,500,000 shares of its common stock at a public offering price of $5.00 per share, which includes 1,500,000 shares sold upon full exercise of the underwriter’s option to purchase additional shares. The gross proceeds from the offering, including the exercise of the over-allotment option, were $57,500,000, before deducting underwriting discounts, commissions and other offering expenses. You can read further details here
Second Sight Medical Products Inc. had a pretty favorable run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $20.00 on 03/09/21, with the lowest value was $1.40 for the same time period, recorded on 03/04/21.
Second Sight Medical Products Inc. (EYES) full year performance was 348.78%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Second Sight Medical Products Inc. shares are logging -78.40% during the 52-week period from high price, and 525.54% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $0.69 and $20.00.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 8115412 for the day, which was evidently higher, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the Second Sight Medical Products Inc. (EYES) recorded performance in the market was 131.02%, having the revenues showcasing -40.98% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 164.68M, as it employees total of 12 workers.
The Analysts eye on Second Sight Medical Products Inc. (EYES)
During the last month, 0 analysts gave the Second Sight Medical Products Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 6.87, with a change in the price was noted +2.58. In a similar fashion, Second Sight Medical Products Inc. posted a movement of +148.28% for the period of last 100 days, recording 18,286,736 in trading volumes.
Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for EYES is recording 0.10 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.00.
Technical rundown of Second Sight Medical Products Inc. (EYES)
Raw Stochastic average of Second Sight Medical Products Inc. in the period of last 50 days is set at 20.76%. The result represents downgrade in oppose to Raw Stochastic average for the period of the last 20 days, recording 44.62%. In the last 20 days, the company’s Stochastic %K was 23.64% and its Stochastic %D was recorded 13.88%.
Considering, the past performance of Second Sight Medical Products Inc., multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be pessimistic, given the fact the metric is recording 131.02%. Additionally, trading for the stock in the period of the last six months notably improved by 117.09%, alongside a boost of 348.78% for the period of the last 12 months. The shares increased approximately by 12.21% in the 7-day charts and went up by -32.92% in the period of the last 30 days. Common stock shares were lifted by -40.98% during last recorded quarter.